Competidores
Simbolo bursátil | Precio | Pronóstico 1A | Pronóstico 2A | Cap. Mercado | Div Yld | Tasa de crecimiento |
---|---|---|---|---|---|---|
NYSE:MRK
Merck
|
130.23 | -9.35% | 3.94% | 329,847.37 | 2.38% | -19.03% |
LSE:AZN
AstraZeneca PLC
|
123.32 | 16.77% | 39.07% | 191,174.98 | 2.02% | 15.98% |
SWX:NOVN
Novartis
|
90.54 | 11.53% | 25.32% | 184,738.39 | 3.64% | 4.67% |
SWX:ROG
Roche Holding
|
222.30 | 33.69% | 50% | 179,414.05 | 4.32% | 0.43% |
ENXTPA:SAN
Sanofi
|
93.18 | 14.19% | 32.35% | 116,348.8 | 4.04% | 8.19% |
LSE:GSK
GSK
|
17.81 | 7.07% | 22.85% | 72,609.46 | 3.27% | 0.79% |
NYSE:BMY
Bristol-Myers Squibb
|
44.74 | 59.17% | 69.35% | 90,692.46 | 5.5% | 13.54% |
ENXTPA:IPN
Ipsen
|
119.60 | -12.53% | -4.32% | 9,647.62 | 1.03% | 9.14% |
ENXTBR:SOLB
Solvay
|
34.39 | 47.96% | 75.37% | 3,650.08 | 7.01% | 9.75% |
NSEI:PFIZER
Pfizer
|
4304.80 | 14.48% | 21.43% | 194,757.24 | 0.82% | 10.3% |
HOSE:DHG
DHG Pharmaceutical Joint Stock
|
113600.00 | 24.25% | 39.02% | 14,918,126.7 | 3.11% | 0% |
ASX:MYX
Mayne Pharma Group
|
7.12 | -,102.84% | -,101.6% | 565.6 | 0% | 0% |
UNQ-VNM:PME
Pymepharco Joint Stock
|
80200.00 | -7.78% | 12.99% | 6,015,932.33 | 2.49% | -0.94% |
HOSE:IMP
Imexpharm
|
66800.00 | 15.58% | 0% | 4,557,302.65 | 1.43% | 0% |
HOSE:DBD
Binh Dinh Pharmaceutical and Medical
Equipment Joint Stock |
52900.00 | 31.14% | 0% | 3,974,188.47 | 3.77% | 21.39% |
HOSE:DCL
Cuu Long Pharmaceutical Joint Stock
|
29000.00 | 0% | 0% | 1,972,107.81 | 0% | 0% |
HOSE:DMC
Domesco Medical Import - Export
Joint-Stock |
56200.00 | 0% | 0% | 1,739,846 | 4.2% | 7.48% |
HOSE:OPC
OPC Pharmaceutical Joint Stock
|
25500.00 | 0% | 0% | 1,614,082.48 | 5.88% | 0% |
HNX:LDP
Lamdong Pharmaceutical Joint Stock
|
23000.00 | 0% | 0% | 284,550.22 | 0% | 0% |
HOSE:DBT
Ben Tre Pharmaceutical Joint Stock
|
12300.00 | 0% | 0% | 207,333.56 | 0% | 0% |